ITGB3 and cancer: confirmed that the upregulated expression of ITGB3 mediated the expression of MMP2 by activating the FAK/PI3K/AKT signaling pathway, contributing to the enhancement of metastatic potential of residual cancer in the HCCLM3 model after insufficient radiofrequency ablation [36].